Working… Menu
Trial record 40 of 52 for:    "Acute Leukemia" | "Anti-Bacterial Agents"

Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03434730
Recruitment Status : Recruiting
First Posted : February 15, 2018
Last Update Posted : August 28, 2019
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : February 7, 2021
Estimated Study Completion Date : February 7, 2021